Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Ischaemia-reperfusion
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseIschaemia-reperfusionCerebral (MCAO/stroke)C57BL/6MaleIntraperitoneal injection (intermittent dosing) or continuous infusion via an implanted infusion pumpIntermittent regimen: 1 h before ischaemia and 1 h and 6 h after the start of r…
Model: Transient focal cerebral ischaemia (1 h middle cerebral artery occlusion) followed by 24 or 72 h of reperfusion
ATK given 1 h before ischaemia and at 1 h and 6 h of reperfusion significantly reduced striatal and hemispheric infarct volume at 24 h, and continuous infusion significantly reduced cortical and whole hemispheric infarct volume at 72 h. No protection was seen when dosing began after ischaemia onset…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.